Trial
NCT06008249
Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Stichting TRICALS Foundation
Collaborators
Fight MND; Research Foundation Flanders; MNDA; Thierry Latran Foundation; Ulla-Carin Lindquist Foundation; Luzon Foundation; Alan Davidson Foundation; My name'5 Doddie Foundation; Stichting ALS Nederland
Condition
Amyotrophic Lateral Sclerosis
Intervention
Lithium Carbonate 400 MG
Why stopped
The planned interim analysis showed no survival benefit of taking the drug when compared with placebo.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-13